Prosorba column: Pilot data; marketed to treat RA and ideopathic thrombocytopenic purpura (ITP)

CYPB published in The Journal of Rheumatology data from a pilot study of the column in 15 patients with RA refractory to disease-modifying anti-rheumatic drugs (DMARDs). Patients in the study received...